Kawasaki disease shock syndrome in the COVID-19 pandemic

Cardiol Young. 2022 Mar;32(3):506-507. doi: 10.1017/S1047951121003280. Epub 2021 Jul 19.

Abstract

Multisystem inflammatory syndrome in children is a new entity in association with SARS-CoV2. Clinical features of Kawasaki disease were noted from the first reported cases of MIS-C. Before the COVID-19 pandemic, Kawasaki disease shock syndrome was considered to be a distinct and unique form of KD. We present a representative case that prove the current difficulty in clearly distinguishing MIS-C from pre-COVID-19-KDSS and emphasie the overlap of the diagnostic criteria.

Keywords: COVID-19; Kawasaki disease; Kawasaki disease shock syndrome; SARS-CoV2; multisystem inflammatory syndrome in children.

MeSH terms

  • COVID-19* / complications
  • Child
  • Humans
  • Mucocutaneous Lymph Node Syndrome* / complications
  • Mucocutaneous Lymph Node Syndrome* / diagnosis
  • Pandemics
  • RNA, Viral
  • SARS-CoV-2
  • Shock* / etiology
  • Systemic Inflammatory Response Syndrome

Substances

  • RNA, Viral

Supplementary concepts

  • pediatric multisystem inflammatory disease, COVID-19 related